Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Case Report

Primary Cardiac Tumors: A Retrospective Study

Author(s): Mona Mlika*, Nouha Daoud, Emna Braham, Adel Marghli and Faouzi El Mezni

Volume 15, Issue 1, 2019

Page: [57 - 61] Pages: 5

DOI: 10.2174/1573398X15666190430122451

Abstract

Objectives: Primary cardiac tumors are rare and account for 0.001 to 0.03% of cardiac lesions. The authors aim to describe the clinical, the microscopic and the therapeutic characteristics of these tumors through a 13-year-experience in order to highlight the diagnostic challenges faced.

Methods: We report 10 primary cardiac tumors diagnosed in the Departments of Pathology and Thoracic Surgery of the same hospital through a 13-year-period.

Results: Our study was conducted on 7 women and 3 men. The mean age of the patients was 54.22 years (average, 12 to 79 years). Dyspnea represented the most frequent symptom. Physical examination was normal in all patients. Trans-thoracic ultra-sound examination was performed in all patients. Cardiac MRI allowed localizing the tumors in 2 patients. They were located into the left auricle (6 cases), the right auricle (1 case) and the pericardium (3 cases). The microscopic examination was concluded to myxoma (7 cases), haemangioma (2 cases) and hemangioendothelioma (1 case). Surgical resection was possible in 9 patients. It was impossible in the case of hemangioendothelioma because of the adherence. One death was recorded secondary to postoperative arrhythmia. The other patients presented no complications after a follow-up period ranging from 2 months to 5 years.

Conclusion: Cardiac tumors are challenging in their diagnosis and management. A positive diagnosis is based on microscopic examination. Surgical treatment plays a key role and is possible in the majority of benign tumors. The prognosis of malignant tumors remains poor even if a complete surgical resection is possible.

Keywords: Cardiac tumors, myxoma, prognosis, sarcoma, retrospective study, pathology.

Graphical Abstract

[1]
Basso C, Rizzo S, Valente M, Thiene G. Cardiac masses and tumours. Heart 2016; 102(15): 1230-45.
[2]
Zakhartseva LM, Zakharova LP, Shatrova KM, Chitaeva GE, Vitovsky RM. Metastatic cardiac tumors: Literature review and own observation of testicular tumor metastasis in the right ventricle of the heart. Exp Oncol 2018; 40(4): 336-42.
[3]
Mousavi N, Cheezum MK, Aghayev A, et al. Assessment of cardiac masses by cardiac magnetic resonance imaging: Histological correlation and clinical outcomes. J Am Heart Assoc 2019; 8(1): e007829.
[4]
Burke AP, Veinot JP, Loire R, Virmani R, Tazelaar H, Kamiya H. Tumors of the heart: Introduction. In: Tumours of the lung, Pleura, Thymus and Heart World Health Organization Classification of Tumours. IARC Press. Lyon 2004; pp. 249-80.
[5]
Bussani R, De-Giorgio F, Abbate A, Silvestri F. Cardiac metastases. J Clin Pathol 2007; 60: 27-34.
[6]
Shapiro LM. Cardiac tumours: Diagnosis and management. Heart 2001; 85: 218-22.
[7]
Denguir R, Dhiab M, Meddeb I, et al. Cardiac myxoma. Surgical treatment. About 20 cases. Ann Cardiol Angeiol 2006; 55: 49-54.
[8]
Zheng JJ, Geng XG, Wang HC, Yan Y, Wang HY. Clinical and histopathological analysis of 66 cases with cardiac myxoma. Asian Pac J Cancer Prev 2013; 14: 1743-6.
[9]
Ferlosio A, Doldo E, Polisca P, Orlandi A. Low-grade fibromyxoid sarcoma: An unusual cardiac location. Cardiovasc Pathol 2013; 22: 15-7.
[10]
Sabageh D, Odujoko OO, Komolafe AO. Right atrial myxoma as a possible cause of hemorrhagic stroke and sudden death. Niger Med J 2012; 53: 102-4.
[11]
Furukawa N, Gummert J, Börgermann J. Complete resection of undifferentiated cardiac sarcoma and reconstruction of the atria and the superior vena cava: Case report. J Cardiothorac Surg 2012; 7: 96.
[12]
Soberman MS, Plauth WH, Winn KJ, Forest GC, Hatcher CR Jr, Sink JD. Hemangioma of the right ventricle causing outflow tract obstruction. J Thorac Cardiovasc Surg 1988; 96: 307-9.
[13]
Brizard C, Latremouille C, Jebara VA, et al. Cardiac hemangiomas. Ann Thorac Surg 1993; 56: 390-4.
[14]
Messias P, Bernardo J, Antunes MJ. Primary left atrial haemangioendothelioma. Interact Cardiovasc Thorac Surg 2008; 7: 945-6.
[15]
Hongquan Y, Hua R, Quancai C, Qi M, Xiaocheng L, Letian X. Cardiac hemangioendothelioma. J Cardiovasc Surg 1998; 39: 655-8.
[16]
Yoshida A, Kanda T, Sakamoto H, et al. Sudden death with malignant hemangioendothelioma originating in the pericardium a case report. Angiology 1999; 50: 607-11.
[17]
Perchinsky MJ, Lichtenstein SV, Tyers GF. Primary cardiac tumors: Forty years’ experience with 71 patients. Cancer 1997; 79: 1809-15.
[18]
Laissy JP, Fernandez P, Mousseaux E, Dacher JN, Crochet D. Cardiac tumors. J Radiol 2004; 85: 363-9.
[19]
Yuan SM, Shinfeld A, Lavee J, Kuperstein R, Haizler R, Raanani E. Imaging morphology of cardiac tumours. Cardiol 2009; 16: 26-35.
[20]
Araoz PA, Mulvagh SL, Tazelaar HD, Julsrud PR, Breen JF. CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics 2000; 20: 1303-19.
[21]
Schvartzman PR, White RD. Imaging of cardiac and paracardiac masses. J Thorac Imaging 2000; 15: 265-73.
[22]
Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. J Cardiovasc Magn Reson 2004; 6: 727-65.
[23]
Nomoto N, Tani T, Konda T, et al. Primary and metastatic cardiac tumors: Echocardiographic diagnosis, treatment and prognosis in a 15-years single center study. J Cardiothorac Surg 2017; 12(1): 103.
[24]
Hoffmeier A, Sindermann JR, Scheld HH, Martens S. Cardiac tumors: Diagnosis and surgical treatment. Dtsch Arztebl Int 2014; 111(12): 205-11.
[25]
Guhathakurta S, Riordan JP. Surgical treatment of right atrial myxoma. Tex Heart Inst J 2000; 27: 61-3.
[26]
Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine 2001; 80: 159-72.
[27]
Ren DY, Fuller ND, Gilbert SAB, Zhang Y. Cardiac tumors: Clinical perspective and therapeutic considerations. Curr Drug Targets 2017; 18(15): 1805-9.

© 2024 Bentham Science Publishers | Privacy Policy